SCHEMBL22912377

SCHEMBL22912377

BC(B)(CCC(CCSCc1ccccc1)SCc1ccccc1)C(=O)OC

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 1/20 0.40
▸ LMNA P02545 3/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ PPARG P37231 2/20 0.35
▸ PPARA Q07869 2/20 0.35
▸ MMP1 P03956 3/20 0.35
▸ MMP2 P08253 3/20 0.35
▸ MMP3 P08254 3/20 0.35
▸ MMP9 P14780 3/20 0.35
▸ MMP13 P45452 3/20 0.35
▸ MMP7 P09237 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22912361 0.84 CYP2C19 (0.38) CYP2C19LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL22912363 0.83 CYP2C19 (0.37) CYP2C19LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL22912360 0.77 CYP2C19 (0.46) CYP2C19LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL13333203 0.77 CYP2C19 (0.46) CYP2C19LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL26613582 0.76 CYP2C19 (0.41) CYP2C19LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL22912362 0.76 CYP2C19 (0.44) CYP2C19LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL22912386 0.75 CYP2C19 (0.39) CYP2C19LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL20395792 0.74 CYP2C19 (0.63) CYP2C19LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL26613581 0.74 CYP2C19 (0.42) CYP2C19LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL20395088 0.73 CYP2C19 (0.56) CYP2C19LMNASMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011334-A1 DEUTERATED DERIVATIVES OF 6,8-BIS(BENZYLSULFANYL)OCTANOIC ACID RAFAEL PHARMACEUTICALS, INC. (US) 2021-01-21 — — WO disclosed
Send feedback